Raul Cordoba: Long-Term Outcomes after HSCT in RR B-Cell Non-Hodgkin Lymphoma
Raul Cordoba, Associate Chief at the Department of Hematology at Jiménez Díaz Foundation, shared a post on X:
“Hematology: Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation HSCT in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative Study.”
Title: Long-Term Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: An Italian Multicenter Collaborative Study
Authors: Corrado Tarella, Simona Sammassimo, Samuele Frassoni, Alida Dominietto, Raffaella Cerretti, Maria Caterina Micò, Rocco Pastano, Martina Pennisi, Maria Chiara Di Chio, Chiara Ghiggi, Gottardo De Angelis, Alessandra Algarotti, Patrizia Chiusolo, Enrico Derenzini, Simona Sica, Paolo Corradini, Vincenzo Bagnardi, Emanuele Angelucci, Alessandro Rambaldi, William G Arcese, Anna Dodero, Andrea Bacigalupo.
You can read the Full Article in Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy.
More posts featuring Raul Cordoba.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023